Evaheart is attending the 2024 American Society for Artificial Internal Organs conference! Tadashi Motomura, Kelsey Smegner, and Jasmine Martinez will be the Evaheart team members in attendance. Please stop by booth#208 and ask them any questions you might have about the EVAHEART LVAS. #LVAD #Heartfailure #LVAS #MedicalDevices #ClinicalTrials #Medicalconference #ASAIO #HeartPump #EVAHEART
Evaheart, Inc.
Biotechnology
Bellaire, Texas 1,983 followers
Our Mission: To return severe heart failure patients to their home with high quality of life.
About us
LEADING LVAD COMPANY IN THE STATE OF TEXAS Evaheart, Inc. ("EVI") is a medical device company based in the Texas Medical Center of Houston. EVI was established to gain regulatory approval and commercialize the EVAHEART®2 Left Ventricular Assist System in the North American market and start distribution in Europe. Under an FDA-approved IDE, a Multi-Center Prospective Randomized Clinical Trial (COMPETENCE TRIAL) of the EVAHEART®2 LVAS is currently ongoing in US. OUR MISSION To return severe heart failure patients to their home with high quality of life. WHAT WE'VE ACHIEVED - Over 9-year durability testing with no mechanical failure. - Regulatory clearance granted (by PMDA) and now clinically used in Japan - Total 183 EVAHEART® LVAS have been implanted to-date (July-2018). - IDE (Investigational Device Exemption) approved by the FDA. - IDE clinical trial (BTT trial) in North America is underway. - New miniaturized pump and inflow cannula are implemented. "RESPECT PULSATILITY"
- Website
-
http://www.evaheart-usa.com
External link for Evaheart, Inc.
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Bellaire, Texas
- Type
- Partnership
- Founded
- 2014
- Specialties
- Left Ventricular Assist Devices & Systems (LVAS)
Products
Locations
-
Primary
4900 Fournace Pl
Suite 222
Bellaire, Texas 77401, US
Employees at Evaheart, Inc.
-
Janice Flynn-Bailey
Senior Clinical Research Associate
-
Robert Benkowski
CEO DesignPlex Biomedical LLC, CEO and co-founder of Opsin Biotherapeutics, Inc.
-
Jim Groneck CCP
Traveling Perfusionist: Adult, Pediatric. Licensed CCP in Arkansas, Texas, Illinois, Georgia, Tennessee, Missouri, Wisconsin.
-
Daniel Wang
Clinical Support Specialist at Evaheart, Inc.
Updates
-
Together, we can reduce the impact of stroke and save lives. This educational content is vital for spreading knowledge about strokes, emphasizing the importance of quick response and preventive measures. Sharing posts during Stroke Awareness Month can enhance community engagement and awareness. #StrokeAwareness #FAST #PreventStroke #AmericanStrokeAssociation
-
We want to show our gratitude and appreciation for the study coordinators and clinical staff that make the COMPETENCE Trial possible. Please watch the video below to see some of the individuals we'd like to recognize their efforts! #clinicaltrials #heartfailure #healthcareworkers #thankfultuesday #bloodpump #MCS #teamwork #grattitude #LVAD
-
Evaheart successfully organized a Lunch and Learn session for the Penn State staff engaged in the COMPETENCE clinical trial. This gathering facilitated the dissemination of updates, allowed the staff to seek clarifications, and encouraged discussions on the future prospects of the EVA2 LVAD. #Clinicaltrial #LVAD #Heartfailure #Medicaldevices #bloodpump #cardiovascular #EVA2
-
Evaheart, Inc. reposted this
Celebrating a milestone in the world of mechanical circulatory support devices! The Evaheart Competence trial for the EVA2 LVAD has successfully completed its 3.5-year mark since the trial began in March of 2020. A big thank you to all the staff and hospitals involved in the trial progression, as we wish for continued success in helping heart failure patients with this new technology. #heartfailure #circulatorysupport #medicaltechnology
-
Celebrating a milestone in the world of mechanical circulatory support devices! The Evaheart Competence trial for the EVA2 LVAD has successfully completed its 3.5-year mark since the trial began in March of 2020. A big thank you to all the staff and hospitals involved in the trial progression, as we wish for continued success in helping heart failure patients with this new technology. #heartfailure #circulatorysupport #medicaltechnology
-
Evaheart hosted a successful Lunch and Learn at Baylor College of Medicine this past week to provide food and a quick presentation to the BCM team to celebrate their efforts in enrolling 8 patients in the COMPETENCE trial. Glad to be able to get most of the BCM team together to provide trial updates and have an open discussion on the EVA2 LVAD. Watch out for our coming post-lunch and learn posts for Christ and University of Louisville coming soon! Big Thanks to Melissa Muñoz Beilis MD, CCRP for helping set this up!
-
Please watch and share this quick video to learn more about the EVA2 LVAS! #research #clinicaltrial #LVAS #LVAD #medicaldevices #bloodpump #cardiovascular #DT #BTT #heartsurgery #patientrecruitment #newtechnology